Robert G. Jr. Spignesi Sells 11,247 Shares of Rapid Micro Biosystems, Inc. (NASDAQ:RPID) Stock

Rapid Micro Biosystems, Inc. (NASDAQ:RPID - Get Free Report) CEO Robert G. Jr. Spignesi sold 11,247 shares of the firm's stock in a transaction on Wednesday, July 9th. The stock was sold at an average price of $3.51, for a total transaction of $39,476.97. Following the completion of the transaction, the chief executive officer directly owned 900,583 shares of the company's stock, valued at approximately $3,161,046.33. This represents a 1.23% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link.

Rapid Micro Biosystems Trading Down 0.3%

Shares of NASDAQ RPID traded down $0.01 during midday trading on Friday, reaching $3.36. The company had a trading volume of 58,625 shares, compared to its average volume of 196,379. The stock has a market cap of $147.28 million, a P/E ratio of -3.26 and a beta of 1.32. Rapid Micro Biosystems, Inc. has a 1 year low of $0.63 and a 1 year high of $4.04. The business's 50-day simple moving average is $3.29 and its 200 day simple moving average is $2.55.

Rapid Micro Biosystems (NASDAQ:RPID - Get Free Report) last released its quarterly earnings results on Friday, May 9th. The company reported ($0.26) EPS for the quarter, beating the consensus estimate of ($0.27) by $0.01. The company had revenue of $7.21 million for the quarter, compared to analyst estimates of $6.63 million. Rapid Micro Biosystems had a negative net margin of 151.22% and a negative return on equity of 56.07%. Analysts predict that Rapid Micro Biosystems, Inc. will post -1.1 earnings per share for the current year.

Institutional Trading of Rapid Micro Biosystems

Several hedge funds and other institutional investors have recently added to or reduced their stakes in RPID. American Century Companies Inc. acquired a new stake in Rapid Micro Biosystems during the first quarter valued at $31,000. Legato Capital Management LLC acquired a new stake in Rapid Micro Biosystems during the first quarter valued at $41,000. Millennium Management LLC grew its position in Rapid Micro Biosystems by 17.6% during the fourth quarter. Millennium Management LLC now owns 61,375 shares of the company's stock valued at $55,000 after buying an additional 9,191 shares during the period. Citadel Advisors LLC acquired a new stake in Rapid Micro Biosystems during the fourth quarter valued at $65,000. Finally, Renaissance Technologies LLC grew its position in Rapid Micro Biosystems by 122.9% during the fourth quarter. Renaissance Technologies LLC now owns 183,087 shares of the company's stock valued at $165,000 after buying an additional 100,942 shares during the period. Institutional investors and hedge funds own 52.60% of the company's stock.

Rapid Micro Biosystems Company Profile

Rapid Micro Biosystems, Inc, a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and customer support and validation services.